BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, January 16, 2026
Home
»
Authors
» James Etheridge
James Etheridge
Articles
ARTICLES
Immutep Closes EUR2.5M Round For Therapeutic Vaccine Development
April 21, 2004
By
James Etheridge
Ablynx Completes EUR25M Series B Financing For Nanobody Platform
April 9, 2004
By
James Etheridge
Ablynx Completes EUR25M Series B Financing For Nanobody Platform
April 9, 2004
By
James Etheridge
Ablynx Completes EUR25M Series B Financing For Nanobody Platform
April 7, 2004
By
James Etheridge
Ablynx Completes EUR25M Series B Financing For Nanobody Platform
April 7, 2004
By
James Etheridge
Innogenetics Gains Therapeutic Vaccine Program From Genencor
March 31, 2004
By
James Etheridge
Innogenetics Gains Vaccine Program From Genencor
March 31, 2004
By
James Etheridge
Innogenetics Gains Therapeutic Vaccine Program From Genencor
March 31, 2004
By
James Etheridge
Innogenetics Gains Vaccine Program From Genencor
March 31, 2004
By
James Etheridge
CareX Raises EUR25M in Second Round To Fund Development
March 10, 2004
By
James Etheridge
View All Articles by James Etheridge
